InnoCare Pharma Limited (HKG:9969)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
13.72
-0.33 (-2.35%)
Apr 29, 2026, 4:08 PM HKT

InnoCare Pharma Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2017
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2017
Net Income
730.32642.47-440.63-631.26-886.59-64.55
Upgrade
Depreciation & Amortization
108.08108.0898.0688.1567.4833.08
Upgrade
Other Amortization
10.2810.289.0711.230.930.63
Upgrade
Loss (Gain) From Sale of Assets
-0-0---0
Upgrade
Asset Writedown & Restructuring Costs
--0.010.02--
Upgrade
Loss (Gain) From Sale of Investments
-58.38-58.38-6.26-5.57-6.46-6.7
Upgrade
Loss (Gain) on Equity Investments
----9.710.6
Upgrade
Stock-Based Compensation
69.6169.61-10.7965.1129.48126.44
Upgrade
Provision & Write-off of Bad Debts
0.410.411.50.27--
Upgrade
Other Operating Activities
-901.3-761.151.9949.17195.01-40.75
Upgrade
Change in Accounts Receivable
-154.95-154.95-63.34-194.53-82.65-45.15
Upgrade
Change in Inventory
-41.83-41.8347.65-42.46-52.12-8.04
Upgrade
Change in Accounts Payable
269.36269.36-2.8-5.613479.08
Upgrade
Change in Unearned Revenue
-----8.7517.19
Upgrade
Change in Other Net Operating Assets
----34.4275.22
Upgrade
Operating Cash Flow
31.683.9-365.55-665.49-565.55167.06
Upgrade
Capital Expenditures
-75.14-70.16-78.23-254.65-227.24-169.77
Upgrade
Sale of Property, Plant & Equipment
0.020.0200.01-0.02
Upgrade
Cash Acquisitions
---1.15--
Upgrade
Sale (Purchase) of Intangibles
-----143.09-1.44
Upgrade
Investment in Securities
-873.07-297.411,056795.85-1,529-1,638
Upgrade
Other Investing Activities
116.11120.53133.75118.71173.3479.57
Upgrade
Investing Cash Flow
-832.08-247.011,111661.06-1,726-1,730
Upgrade
Long-Term Debt Issued
-260.931,18533.832550
Upgrade
Total Debt Issued
554.2260.931,18533.832550
Upgrade
Long-Term Debt Repaid
--264.04-990.41-28.98-21.78-14.92
Upgrade
Total Debt Repaid
-328.08-264.04-990.41-28.98-21.78-14.92
Upgrade
Net Debt Issued (Repaid)
226.12-3.11194.914.82303.2335.08
Upgrade
Issuance of Common Stock
19.8618.9818.59.952,9232,527
Upgrade
Repurchase of Common Stock
-16.66-16.66-13.35-6.3--
Upgrade
Common Dividends Paid
-33.64-32.92-362.93-1.15--
Upgrade
Other Financing Activities
7.5986.42-122.73-6.01-131.95-17.74
Upgrade
Financing Cash Flow
203.2752.71-285.591.313,0952,545
Upgrade
Foreign Exchange Rate Adjustments
-121.29-62.6416.9225.7139.9-45.3
Upgrade
Net Cash Flow
-718.5-173.05476.922.58942.5936.6
Upgrade
Free Cash Flow
-43.5413.74-443.78-920.14-792.79-2.71
Upgrade
Free Cash Flow Margin
-1.73%0.58%-43.96%-124.59%-126.76%-0.26%
Upgrade
Free Cash Flow Per Share
-0.030.01-0.26-0.54-0.54-0.00
Upgrade
Cash Interest Paid
----3.262.53
Upgrade
Cash Income Tax Paid
187.74138.6889.2558.78--
Upgrade
Levered Free Cash Flow
298.04440.46-649.68-777.19-236.9535.82
Upgrade
Unlevered Free Cash Flow
331.87474.29-628.56-755.19-226.2937.47
Upgrade
Change in Working Capital
72.5972.59-18.49-242.6-75.1118.3
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.